Treatment of renal osteodystrophy with 1,25-dihydroxycholecalciferol.

Nine patients with renal osteodystrophy were tested for 6.5 to 35 months with 1,25-dihydroxycholecalciferol (1,25-DHCC). A close biochemical follow-up was performed during the first 6 months of treatment, including biweekly determinations of serum calcium, phosphorus, magnesium, alkaline phosphatase...

Full description

Saved in:
Bibliographic Details
Main Authors: Velentzas, C, Oreopoulos, D G, Pierratos, A, Meema, H E, Rabinovich, S, Meindok, H, Husdan, H, Murray, T M, Ogilvie, R, Katirtzoglou, A
Format: Artigo
Language:Inglês
Published: 1981
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1705195/
https://ncbi.nlm.nih.gov/pubmed/6894103
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items